NASDAQ:GLMD
Galmed Pharmaceuticals Ltd.
- Stock
Last Close
0.31
26/07 20:00
Market Cap
1.82M
Beta: 1.13
Volume Today
6.14K
Avg: 220.86K
PE Ratio
−0.31
PFCF: −0.15
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -2.95M - | -3.08M 4.58% | -262K 91.51% | -177K 32.44% | -50K 71.75% | -13.97M 27,838% | -15.87M 13.63% | -1.90M 88.01% | 57K - | |||
average payables | 878K - | 1.11M 26.99% | 1.57M 40.54% | 2.69M 71.70% | 2.70M 0.32% | 2.04M 24.23% | 3.91M 91.03% | 6.52M 66.97% | 5.96M 8.65% | 3.72M 37.64% | 2.22M 40.26% | |
average receivables | 10.50K - | 37.50K 257.14% | 221.50K 490.67% | 331.50K 49.66% | 219.50K 33.79% | 103K 53.08% | 439K 326.21% | 819.50K 86.67% | 968.50K 18.18% | 624.50K 35.52% | 144.50K 76.86% | |
book value per share | -2.74 - | 45.63 1,764.55% | 29.11 36.20% | 14.60 49.84% | 18.97 29.91% | 72.69 283.11% | 49.62 31.73% | 31.12 37.29% | 18.60 40.24% | 0.53 97.13% | 5.01 838.67% | |
capex per share | -0.02 - | -1.12 6,024.55% | -0.21 80.80% | -0.02 89.57% | -0.03 12.52% | -0.07 195.06% | -0.01 88.55% | -0.03 263.80% | -0.01 78.37% | -0.00 97.63% | ||
capex to depreciation | -3.25 - | -85.56 2,532.48% | -3.18 96.28% | -0.10 96.84% | -0.09 12.65% | -0.23 164.67% | -0.34 47.43% | -1.13 229.06% | -0.26 76.79% | -0.11 56.36% | ||
capex to operating cash flow | 0.01 - | 0.08 1,517.77% | 0.02 77.48% | 0.00 92.53% | 0.00 24.16% | 0.01 473.15% | 0.00 91.95% | 0.00 108.35% | 0.00 80.02% | 0.00 35.35% | ||
capex to revenue | -0.04 - | -0.02 46.83% | -0.04 128.16% | |||||||||
cash per share | 0.19 - | 46.47 24,041.62% | 31.08 33.12% | 20.37 34.46% | 22.82 12.02% | 74.59 226.85% | 53.63 28.10% | 35.87 33.12% | 21.23 40.81% | 0.55 97.42% | 4.61 740.26% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 22.12K - | |||||||||||
days sales outstanding | 221.97 - | 52.14 76.51% | 9.13 82.48% | |||||||||
debt to assets | 0.00 - | 0.00 9.63% | 0.01 51.71% | 0.00 57.53% | ||||||||
debt to equity | 0.01 - | 0.00 2.92% | 0.01 53.49% | 0.00 56.35% | ||||||||
dividend yield | ||||||||||||
earnings yield | -1.72 - | -2.28 32.82% | -1.89 17.29% | -6.37 237.69% | -1.57 75.30% | -1.19 24.15% | -2.28 90.95% | -6.26 174.59% | -10.70 71.06% | -1.48 86.20% | -5.49 271.31% | |
enterprise value | 10.05M - | -19.74M 296.52% | 1.48M 107.47% | -435.33K 129.50% | -5.20M 1,095.39% | -15.90M 205.54% | -7.44M 53.19% | -2.32M 68.85% | 329.51K 114.21% | 10.60M 3,116.68% | -1.72M 116.21% | |
enterprise value over ebitda | -0.69 - | 2.16 413.26% | -0.14 106.31% | 0.03 119.11% | 0.43 1,547.72% | 1.54 258.12% | 0.33 78.32% | 0.08 76.93% | -0.01 113.06% | -0.62 6,067.97% | 0.23 137.20% | |
ev to operating cash flow | -3.98 - | 2.14 153.68% | -0.17 108.15% | 0.04 120.61% | 0.43 1,101.54% | 1.76 308.62% | 0.50 71.72% | 0.09 82.30% | -0.01 111.36% | -0.57 5,618.78% | 0.28 148.86% | |
ev to sales | -0.93 - | -4.80 414.51% | -7.80 62.67% | |||||||||
free cash flow per share | -3.56 - | -14.55 308.02% | -11.67 19.80% | -16.02 37.30% | -14.52 9.35% | -7.54 48.10% | -10.62 40.91% | -18.56 74.76% | -20.06 8.11% | -0.74 96.33% | -2.22 201.07% | |
free cash flow yield | -0.25 - | -2.51 906.69% | -1.53 38.87% | -4.56 197.68% | -1.55 66.11% | -1.10 28.64% | -1.84 66.51% | -5.97 224.80% | -11.02 84.74% | -1.47 86.65% | -4.87 230.85% | |
graham net net | -2.77 - | 40.05 1,545.63% | 27.61 31.07% | 13.40 51.48% | 18.28 36.43% | 72.38 296.02% | 38.97 46.16% | 29.16 25.19% | 18.02 38.19% | 0.43 97.63% | 3.66 756.50% | |
graham number | 38.93 - | 116.53 199.34% | 96.97 16.79% | 85.71 11.61% | 79.42 7.35% | 115.46 45.39% | 121.27 5.03% | 116.74 3.74% | 90.29 22.66% | 2.98 96.70% | 16.78 463.18% | |
income quality | 0.14 - | 1.02 603.25% | 0.80 21.41% | 0.72 10.32% | 0.98 37.14% | 0.92 6.69% | 0.73 20.26% | 0.91 25.16% | 1.01 10.88% | 1.04 2.22% | 0.89 14.26% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -82.10 - | -681.09 729.61% | ||||||||||
interest debt per share | 0.25 - | 0.15 39.12% | 0.14 8.28% | 0.01 92.62% | 0.00 61.44% | |||||||
inventory turnover | ||||||||||||
invested capital | 0.01 - | 0.00 2.92% | 0.01 53.49% | 0.00 56.35% | ||||||||
market cap | 10.18M - | 3.99M 60.80% | 5.63M 41.08% | 2.66M 52.74% | 7.82M 193.69% | 8.26M 5.65% | 8.14M 1.48% | 4.41M 45.77% | 2.98M 32.36% | 12.57M 321.22% | 1.26M 89.98% | |
net current asset value | -1.96M - | 30.63M 1,659.73% | 20.66M 32.55% | 10.36M 49.87% | 15.30M 47.76% | 87.70M 473.05% | 69.14M 21.16% | 43.58M 36.97% | 29.95M 31.29% | 11.59M 61.31% | 10.49M 9.47% | |
net debt to ebitda | 0.01 - | 2.60 27,516.92% | 0.38 85.23% | 0.19 51.73% | 1.07 479.53% | 2.34 117.46% | 0.70 70.14% | 0.22 68.01% | 0.08 63.76% | 0.12 42.42% | 0.40 246.64% | |
net income per share | -24.57 - | -13.23 46.17% | -14.35 8.52% | -22.36 55.76% | -14.77 33.92% | -8.15 44.83% | -13.17 61.60% | -19.46 47.75% | -19.48 0.11% | -0.74 96.21% | -2.50 237.89% | |
operating cash flow per share | -3.55 - | -13.43 278.58% | -11.45 14.72% | -15.99 39.68% | -14.50 9.38% | -7.46 48.52% | -10.61 42.21% | -18.53 74.61% | -20.06 8.25% | -0.74 96.33% | -2.22 201.14% | |
payables turnover | 0.02 - | |||||||||||
receivables turnover | 1.64 - | 7 325.70% | 39.96 470.87% | |||||||||
research and ddevelopement to revenue | 30.56 - | 8.89 70.90% | 4.08 54.14% | |||||||||
return on tangible assets | -105.33 - | -0.28 99.74% | -0.44 58.34% | -1.03 135.41% | -0.63 39.25% | -0.11 82.63% | -0.24 120.95% | -0.53 119.30% | -0.87 65.58% | -1.12 28.48% | -0.42 62.93% | |
revenue per share | 0.62 - | 1.30 111.63% | 1.69 29.32% | |||||||||
roe | 8.96 - | -0.29 103.23% | -0.49 70.10% | -1.53 210.49% | -0.78 49.13% | -0.11 85.60% | -0.27 136.70% | -0.63 135.59% | -1.05 67.53% | -1.38 32.07% | -0.50 64.00% | |
roic | 7.47 - | -0.29 103.90% | -1.51 420.17% | -1.53 1.30% | -1.57 2.33% | -0.12 92.17% | -0.29 133.94% | -0.65 126.27% | -1.05 60.75% | -1.36 29.92% | -0.54 60.25% | |
sales general and administrative to revenue | 6.59 - | 3.50 46.88% | 2.18 37.78% | |||||||||
shareholders equity per share | -2.74 - | 45.63 1,764.55% | 29.11 36.20% | 14.60 49.84% | 18.97 29.91% | 72.69 283.11% | 49.62 31.73% | 31.12 37.29% | 18.60 40.24% | 0.53 97.13% | 5.01 838.67% | |
stock based compensation to revenue | 3.49 - | 1.28 63.15% | 0.87 31.91% | |||||||||
tangible asset value | -1.95M - | 31.41M 1,709.79% | 21.55M 31.40% | 11.07M 48.60% | 15.79M 42.62% | 87.89M 456.47% | 69.85M 20.53% | 44.15M 36.79% | 30.50M 30.93% | 13.42M 55.99% | 13.88M 3.40% | |
tangible book value per share | -2.74 - | 45.63 1,764.55% | 29.11 36.20% | 14.60 49.84% | 18.97 29.91% | 72.69 283.11% | 49.62 31.73% | 31.12 37.29% | 18.60 40.24% | 0.53 97.13% | 5.01 838.67% | |
working capital | -1.54M - | 31.03M 2,120.38% | 20.84M 32.85% | 11.15M 46.48% | 15.30M 37.22% | 87.70M 473.05% | 69.50M 20.76% | 43.80M 36.98% | 30.18M 31.11% | 11.63M 61.46% | 10.49M 9.81% |
All numbers in USD (except ratios and percentages)